Overview of CJC-1295 in Laboratory Research
CJC-1295 is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) that has been the subject of controlled experimental studies. Its primary molecular feature is the incorporation of a maleimidopropionic acid (MPA) conjugation moiety, which facilitates selective binding to serum albumin, thereby extending the peptide’s half-life in research models. In laboratory settings, CJC-1295 is employed to investigate the pulsatile release of growth hormone and downstream signaling cascades. Researchers use it to study endocrine pathways, receptor-ligand interactions, and the pharmacokinetic behavior of long-acting peptide analogues in in vitro systems or approved animal models. All handling of this compound must be confined to professional research environments, and it is strictly not for human or veterinary application. The peptide is supplied as a lyophilized powder of known sequence—typically comprising the first 29 amino acids of GHRH with the MPA substitution—enabling precise experimental dosing under strict protocol control.
Bulk Ordering Considerations for Research Institutions
Procuring CJC-1295 in larger quantities is a strategic decision that can yield significant operational advantages for laboratories engaged in extensive or longitudinal studies. Consolidating purchases into bulk orders often reduces the per-unit cost, as suppliers can optimize synthesis and purification runs. Equally important, obtaining a single, well-characterized lot ensures intra-study consistency, eliminating the variable of batch-to-batch variation that can confound results. Buyers must, however, align order volumes with available cold storage capacity and staff proficiency in handling lyophilized peptides under inert atmosphere. Proper inventory rotation and stability management are essential; the peptide’s long-term integrity relies on storage at -20°C or below, protected from moisture and repeated freeze-thaw cycles, which may degrade the research material over time.
Minimum Order Quantities for CJC-1295
Suppliers of research peptides commonly define minimum order quantities (MOQs) to balance production economics with market demand. For standard catalog-grade CJC-1295, typical minimums range from 100 mg to 1 gram of net peptide content, although this can differ markedly among manufacturers. Factors such as whether the product is offered as pre-aliquoted vials or bulk powder influence the threshold; pre-filled vials may be subject to a minimum number of units, while bulk powder is often sold by net weight. In cases where a research institution requires a custom synthesis—for example, a specific salt form or a non-standard purity level—the minimum order quantity can be substantially higher, frequently starting at 5 grams or more, as the fixed costs of dedicated equipment cleaning, process validation, and analytical testing are amortized over a larger batch.
Factors Influencing Minimum Quantity Requirements
Several technical and regulatory variables determine the MOQ that a manufacturer imposes. Production batch size is a primary driver: automated solid-phase peptide synthesizers operate efficiently within a defined scale range, and deviating below that range may compromise coupling efficiency or yield consistency. A minimum volume of crude peptide is also necessary to perform the required purification (typically by preparative HPLC) and still deliver the requested net quantity after losses during fraction collection and lyophilization. Stability data generation and the mandatory quality control panel—encompassing HPLC purity, mass spectrometry, and often residual solvent or counterion analysis—consume a portion of each batch, setting a lower practical limit. For international shipments, import/export regulations may establish administrative thresholds; for instance, certain jurisdictions require an end-use declaration or permit for quantities that exceed a specified weight, influencing the MOQ that suppliers are willing to ship to a given region.
Quality Assurance in Bulk CJC-1295 Shipments
Any batch intended for research must be accompanied by a comprehensive Certificate of Analysis (CoA) that attests to its identity, purity, and physicochemical properties. The CoA typically lists the lot number, date of manufacture, retest date, and results of key assays. For a peptide like CJC-1295, which may be used in sensitive binding or cellular response experiments, the absence of biological contaminants is critical. Conscientious researchers request, or contract third-party laboratories to perform, additional assays for endotoxin (a common bacterial byproduct that can skew cell-based assays), heavy metals, and microbial sterility. Such supplementary testing ensures that the delivered material meets the rigorous specifications demanded by modern research programs and supports reproducible experimental outcomes.
Purity Analysis and Documentation
High-performance liquid chromatography (HPLC) is the cornerstone of peptide purity assessment, with most research-grade suppliers committing to a specification of >98% as determined by area integration at 214 nm or 220 nm. The CoA should present the chromatogram, the column type, and solvent gradient conditions. Mass spectrometry (MS), usually electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI), confirms that the observed molecular weight matches the theoretical mass of the CJC-1295 sequence with the albumin-binding moiety (approximately 3367 Da for the base sequence). When ordering in bulk, researchers may also request amino acid analysis to verify the molar ratio or quantification of the conjugated maleimide group. Batch-specific documentation is a fundamental component of good research practice, enabling principal investigators to trace any anomaly back to the source material.
Packaging and Shipping for Bulk Orders
The physical form and packaging of a bulk CJC-1295 shipment directly affect the material’s integrity upon arrival. Lyophilized peptide is typically dispensed into sterile, Type I borosilicate glass vials sealed under vacuum or an inert gas such as argon to prevent oxidative degradation. For powder quantities exceeding the capacity of a single vial, suppliers may use multiple vials or, for high-volume orders, provide the peptide in single, larger resealable containers (e.g., amber glass jars or multi-layer foil-laminate bags with integrated desiccant sachets). Temperature control during transit is standardized for many shipments: research peptides are often shipped at ambient temperature with ice packs only for long journeys, but specialized cold-chain packaging (2–8°C or deep-frozen on dry ice) is available upon request. International consignments require accurate, non-commercial invoice labeling—designating the contents as “research chemicals” or “non-hazardous synthetic peptide”—and clear, customs-compliant documentation to avoid clearance delays.
Regulatory Compliance for Research Peptide Import/Export
The cross-border movement of CJC-1295 is subject to the import and export control regulations of the originating and destination countries. Because the peptide has no approved therapeutic indication and is solely a laboratory tool, it typically falls under the purview of chemical control lists rather than pharmaceutical legislation, but this varies. Buyers are responsible for verifying that the substance can be lawfully imported for their stated research purpose and must be prepared to provide an end-user certificate or a signed statement of non-human use if required by the supplier or by local authorities. Reputable suppliers will furnish a material safety data sheet (MSDS) detailing handling precautions, personal protective equipment recommendations, and first-aid measures in the event of accidental exposure. Adherence to these protocols is mandatory to maintain the ethical and legal integrity of the research enterprise.
Frequently Asked Questions About Bulk Orders
How is minimum quantity determined?
The minimum order quantity is calculated by the supplier based on the economic batch size for synthesis and purification, the volume of material consumed during quality control testing, and the administrative overhead for documentation and shipping. It is not an arbitrary figure but a practical constraint rooted in production cost structures.
Can I negotiate lower minimums for long-term partnerships?
In some cases, an established relationship may allow for flexibility. A buyer who commits to a series of regular shipments over a fixed period might obtain a lower per-order minimum, as the supplier can allocate part of a larger production run. Such arrangements are evaluated on a case-by-case basis and often require a formal supply agreement.
What is the lead time for bulk production?
Standard catalog items may ship within days to a few weeks, assuming available inventory. Custom synthesis, or the production of a new bulk lot from the ground up, generally requires 6–10 weeks, including synthesis, purification, lyophilization, QC testing, and release.
Are samples available before placing a bulk order?
Many suppliers can provide a small, paid sample of a previous lot for preliminary evaluation. This allows the research team to verify solubility, stability in their specific buffer system, and activity in pilot assays before committing to a significant purchase, thereby reducing risk.
Conclusion: Procuring CJC-1295 for Research
Placing a bulk order for CJC-1295 can be a prudent approach for research groups that require a consistent, high-quality supply to support extensive experimental series. The investment compels attention to the supplier’s minimum quantity policies, the rigor of their quality assurance program, and the specifics of packaging and shipping logistics. By thoroughly evaluating these elements—requesting CoAs, confirming purity specifications, and aligning the order size with projected usage—laboratories can secure a material that underpins reproducibility and scientific validity. As always, every shipment is intended exclusively for laboratory investigation, and all handling must observe the relevant institutional, local, and international regulatory frameworks.
Research use only notice: All products described, including CJC-1295, are furnished strictly for in vitro research or approved animal studies, and are not for diagnostic, therapeutic, human, or veterinary use. Buyers must ensure that their intended application fully complies with applicable law and that the product is handled only by qualified professionals in controlled laboratory settings.
Nur für Forschungszwecke. Nicht zur Anwendung am Menschen oder bei Tieren bestimmt.
